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Abstract
Background: Papua New Guinea (PNG) is a diverse and culturally-rich country with severe infrastructural and health
problems. Tuberculosis (TB) is widespread, and the number of cases with drug resistance is rising. Treatment
adherence is known to be important for both effective treatment and limiting the emergence of drug resistance.
The aim of this study was to construct a matrix of the factors that act as facilitators or barriers to TB treatment
adherence in a remote region of PNG.
Methods: The study was based in the Balimo region of the Western Province. People known to have undergone
TB treatment, as well as staff involved in managing people with TB, were asked to participate in an in-depth
interview about their experiences. Purposive sampling was used to identify a diverse range of participants, from
different geographic locations, social backgrounds, and with successful and unsuccessful treatment outcomes. The
interview data was analysed based on grounded theory methodology.
Results: The study identified a range of factors that influence TB treatment adherence, with these being classified
as personal, systems, and sociocultural. These factors are presented along with suggested recommendations for
adaptations to DOTS-based treatment in this region. Barriers included the challenges associated with travel to
treatment sites, and the difficulties of undertaking treatment alongside the daily need to maintain subsistence food
production. However, facilitators were also identified, including the positive influence of religious beliefs, and high
confidence in the ability of DOTS-based treatment to cure TB.
Conclusions: Documenting the wide range of factors that influence treatment adherence in a severely affected
remote population will assist in improving TB control. These results provide impetus for further community-based
efforts aimed at improving access to TB diagnosis and treatment, and maintaining successful treatment outcomes
in the face of emerging drug resistance.
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Background
The treatment of tuberculosis (TB) is an arduous under-
taking for patients, requiring six months of daily treat-
ment with multiple drugs, and regimens of up to two
years where cases are drug-resistant. The challenges of
TB treatment have led to the development of the World
Health Organization (WHO)-recommended directly
observed treatment, short-course (DOTS) strategy for
treatment [1].
There is no doubt that the use of DOTS has enabled
treatment and improved outcomes for many TB pa-
tients. For example, in Ethiopia and the Solomon
Islands, DOTS has resulted in increased treatment suc-
cess rates and decreased treatment default rates in TB
patients [2, 3]. Despite this success, DOTS typically
doesn’t fully account for the influence of sociocultural
and structural factors on health and healthcare delivery,
which can influence TB treatment in many ways.
The worldwide emergence of drug-resistant TB (DR-
TB) makes the influence of sociocultural and structural
factors on treatment adherence even more important.
Factors that result in delayed diagnosis and treatment in-
terruptions increase the likelihood of both generating
and selecting genetic mutations that confer antimicrobial
resistance. Furthermore, the establishment of drug-
resistant strains enables primary transmission of these
strains to others. Understanding facilitators and barriers
to treatment is therefore essential in local TB control
programs.
In Papua New Guinea (PNG), TB contributes signifi-
cantly to the burden of disease. In 2014, the WHO esti-
mate of incidence was 417 cases per 100,000 people,
with multidrug resistance estimated at 2.7% in new
cases, and 19% in retreatment cases [4]. However,
region-specific studies in PNG have suggested higher
rates of TB and drug resistance, with incidence estimates
of 550–1290 cases per 100,000 people, and multidrug re-
sistance in 5–25% of patients [5–10].
Research in PNG has described a diversity of beliefs
about health, illness and treatment [11]. Furthermore, a
number of sociocultural and structural barriers to TB
treatment have been described. These include poor
health facilities, overcrowding, isolation, certain ‘un-
healthy’ behaviours, and cultural beliefs [12].
The aim of this study was to identify factors influen-
cing TB treatment adherence in the remote Balimo re-
gion of PNG. Identifying these factors is an initial step
in supporting and strengthening the local TB control
program, thus enabling patients to adhere to treatment,
and stemming the rise of DR-TB. Furthermore, regional
factors such as geographical challenges and predomin-
antly subsistence-based lifestyles make the results of this




The study was based in the Balimo region in the Middle
Fly District of the Western Province of PNG (Fig. 1).
The area has a population of about 37,000, with about
4000 in the Balimo town area. The majority of the popu-
lation belong to the Gogodala local language group.
There is strong influence from colonial history in
PNG, with the population predominantly identifying as
Christian [13]. However, traditional beliefs and practices,
including witchcraft and sorcery, are still influential in
everyday life [14].
PNG has a rugged and varied landscape, with the ma-
jority of the population living in rural areas. The Balimo
region is situated on the Aramia River floodplain, with
Balimo adjacent to a large lagoon. Transport in the area
is primarily by boat, ranging from dugout canoes pad-
dled by hand to larger canoes, and, less commonly, in
fibreglass dinghies powered by outboard motors. Road
networks are extremely limited, with vehicle transport
restricted to the town area. As a result, travel for pur-
poses such as accessing health care, which may be lo-
cated far from home, can be both lengthy and costly.
Balimo has two hospitals, however there is no phys-
ician. Clinical decisions are made by a health extension
officer and nursing staff. Facilities such as surgery and x-
ray are not available, so clinical investigations and spu-
tum testing using Ziehl-Neelsen microscopy are used for
diagnosis. Suspected TB cases must travel to Balimo,
often from very remote sites, as this is the only health fa-
cility in the District able to diagnose TB and initiate
DOTS-based TB treatment. Accessing TB services may
therefore be particularly difficult for those who are ill, or
who live in remote villages.
The majority of the population are engaged in subsist-
ence agriculture as the primary means of food produc-
tion. This involves travelling by boat or by foot to
camping places and gardens, or fishing in the extensive
lagoon system, as the primary means of food production.
The subsistence-based lifestyle means cash income is
very limited for most.
Study design
This study used in-depth interviews and site visits to ex-
plore the lived experience of people who have undergone
TB treatment. The study primarily aimed to gather pa-
tient perspectives of treatment adherence, however a
small number of health workers were also interviewed to
give further depth to the findings. In addition to their
own experiences, interview participants acted as lay field
observers, providing insights into complex social systems
and structures that may influence TB control, including
cultural beliefs and practices, village obligations, food se-
curity, family life, and health systems. Participants were
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recruited by local health workers using purposive and
maximum variation sampling to identify people with a
diverse range of treatment experiences. The site visits
added rich observational data that enhanced the inter-
view findings.
Interviews were semi-structured and lasted for ap-
proximately 30–60 min. Initial questions gathered demo-
graphic and social data, including age, family details,
living arrangements, and education (Additional file 1).
The interview body aimed to collect accounts of each
participant’s individual experience with TB treatment, as
well as their observations of others, in order to develop
a composite model of as many factors as possible that
potentially impinge on treatment adherence. The con-
tent of interviews was highly variable by design;
interviews aimed to include both clinical and contextual
issues, including treatment experiences; delays in diag-
nosis and treatment; access pathways to treatment; ser-
vices and support; beliefs about the causes of TB; drug
side effects; treatment adherence; attitudes and beliefs
about treatment; social systems and organisation; sup-
port networks; and cultural contexts. Staff interviews fo-
cused on past and present approaches to TB treatment
in Balimo, and only data relevant to treatment adherence
was included in these results.
Study population
A total of 21 individual interviews were conducted.
Participants were briefed on the nature of the study,
and verbal informed consent was obtained prior to
Fig. 1 Papua New Guinea, showing Western Province, and Balimo in the Middle Fly District
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each interview. Eleven interviews (including four with
staff members) were conducted at Balimo District
Hospital, with the remaining ten undertaken during
site visits in outlying villages. Participants were given
the option of being interviewed in English or the
local Gogodala language. Two local community nurses
acted as translators and cultural advisers in all patient
interviews where required. All health worker inter-
views were conducted in English.
Participants interviewed about their treatment expe-
riences ranged in age from 23 to 61, and included 11
males and 6 females. Demographic factors of the 17
participants interviewed about their treatment experi-
ences are shown in Table 1. Where housing density
was able to be identified, this ranged from 1.25 to 11
people per room. The health worker participants were
aged from 28 to 51, with one female and three males,
and with a broad range of education and expertise.
Although the 21 interviews traced individual patient
and health worker journeys, participant observations of
social and cultural influences resulted in data relevant to
the broader social and community context. Thus the
sample for this study incorporates the broader social
structures and systems, beyond the individual key infor-
mants themselves.
Data analysis
All interviews were digitally recorded in duplicate. Inter-
view transcripts were manually coded using open and
axial coding [15]. Analytic memos documented details of
emerging codes and categories throughout the coding
process. Analysis was based on adapted grounded theory
methodology, aiming to develop a matrix of factors and
subsequently an explanatory model for the factors that
influence treatment adherence [16, 17].
Human ethics approval
The study was approved by the James Cook University
Human Research Ethics Committee under approval
number H5661. The Middle Fly District Health Service
and the Evangelical Church of Papua New Guinea
Health Service gave both verbal and written permission
and support for the project. The PNG Medical Research
Advisory Committee approved the study.
Results and discussion
Standard management of TB in the Balimo region is
based on the DOTS strategy. Ideally, this means that pa-
tients who are deemed infectious (i.e. sputum smear-
positive for Acid Fast Bacilli), as well as those who are
particularly unwell, are admitted to the hospital TB ward
for two weeks, or until considered non-infectious. How-
ever, limited hospital beds means this does not always
occur. The approach to treatment is therefore pragmatic
and flexible out of necessity. Patients may stay in or
around the Balimo township during treatment, returning
to the hospital each day for treatment observation.
Others return home, with their treatment observed by a
treatment supporter or family member. Some patients
may take their treatment unobserved, returning to
Balimo only to replenish their medication.
In this study, 12/17 (70.6%) participants interviewed
about their experiences with TB treatment reported never
having missed a treatment dose. The interview data re-
vealed a number of sociocultural and structural factors
that may act as barriers and facilitators in TB treatment
adherence. These factors were apparent based on a range
of experiences, including patients who missed, who came
close to missing, or were tempted to miss doses, as well as
lay experience based on observation of others undergoing
treatment. Influencing factors are considered from per-
sonal, systems, and sociocultural perspectives.
Personal factors
Personal experience
People undergoing TB treatment in the Balimo region
have a knowledge base from which they approach treat-
ment. This is composed of personal experience, observa-
tions, interactions with others, and the development of
belief systems. These influences can occur long before a
Table 1 Demographic and social factors of participants
interviewed about their TB treatment experiences
Location Urban (Balimo) 7/17 (41.2%)
Outlying village 10/17 (58.8%)
Sex Male 11/17 (64.7%)
Female 6/17 (35.3%)






Education Primary (Grades 1–6) 8/17 (47.1%)
High school (Grades 7–12) 3/17 (17.6%)
College/Tertiary 4/17 (23.5%)
Unknown 2/17 (11.8%)
Living status Employed 4/17 (23.5%)
Predominantly subsistence 10/17 (58.8%)
Student 1/17 (5.9%)
Home duties 1/17 (5.9%)
Unknown 1/17 (5.9%)
Relationship status Married 13/17 (76.5%)
Separated 1/17 (5.9%)
Unmarried 3/17 (17.6%)
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person is actually diagnosed with TB, and only later be-
come relevant to the treatment experience. For example:
Once he was commenced on treatment, he had
confident that he was going to get better. But then, he
is not gaining weight … He has seen other people
who were on TB treatment, they gained weight, they
are healthy, but not him. (42 year-old male, urban,
employed; translation)
Knowledge, or the lack of it, as well as a variety of be-
liefs about the cause of TB, were described as influences
in the non-acceptance of a TB diagnosis, and resultant
difficulties in adherence:
There are times other patients who will be openly
accepting that they have TB. Others will still consider
the other issues like it’s witchcraft or it’s a sin. They
could be that. They struggle through. (39 year-old
female, urban, employed)
Such examples demonstrate the capacity of observa-
tion, experience, knowledge, and beliefs to act as both
facilitators and barriers in treatment. Furthermore, dif-
fering beliefs about TB causation seem to reflect efforts
to explain TB based on personal experiences, despite
limited knowledge of the biomedical basis of disease.
These factors may be influential throughout the treat-
ment journey, in treatment-seeking, acceptance of a
diagnosis, and adherence.
Responses to treatment
Physical responses to treatment influenced adherence.
People undergoing treatment and health workers re-
ported relatively few side effects, or that effects disap-
peared rapidly after initiating treatment. It was noted
that having foreknowledge of potential side effects, such
as a change in urine colour – a standard feature of treat-
ment with rifampicin – was important. However, numer-
ous participants reported a simple desire to get better
and get on with life, with this being sufficient to
overcome challenges. For example:
She developed the side effects and then husband told
her, maybe this one of the cause that other people
don’t like TB [treatment] … because of the side
effects. And they go off the treatment. And then what
she told her husband is, that’s them, but this is my
life. We all have one life here so I need to complete
the treatment. (41 year-old female, village, subsistence;
translation)
Feeling better following treatment initiation with re-
sultant abandonment of treatment is commonly reported
in the literature [18–20]. Although this was described by
two participants in this study, it appeared to be unusual.
Rather, it was far more common for participants to re-
port that feeling better encouraged them to continue
treatment, even if side effects occurred.
Although responses to side effects varied, it was clear
that education about potential effects was important.
Furthermore, ensuring that patients understand the need
to continue with treatment, regardless of whether they
feel better, worse, or no change at all, should be empha-
sised. This is particularly important in a setting where
low levels of education are not unusual (Table 1), and in
combination with beliefs in sorcery and inadequate
science-based knowledge of disease, may combine to
undermine antibiotic treatment efforts. However, pa-
tients should also be educated that feeling worse, or de-
veloping side effects, should prompt review by a health
worker.
Competing priorities
Competing priorities were a prominent influence on
treatment adherence. Missing treatment due to work-
related responsibilities was mentioned by two partici-
pants. However, for a primarily subsistence-based
population such as the Gogodala people, possibly the
most important consideration is food production, as
described here:
… last year I left the medicine, treatment. I was busy
planting bananas … That’s another reason, last year I
left the medicine, I was in the bush. (39-year-old
male, village, subsistence)
TB and HIV treatment adherence literature describe
another consequence of food shortages on adherence,
with patients unwilling to take treatment on an empty
stomach due to possible side effects, increased hunger
due to recovery, and believing that medications taken
without food are harmful [21–23]. Concern about taking
medicine without food was reported in Balimo. This was
particularly when there were food shortages. Such short-
ages are also linked with the economic burden created
by the need to be away from home for treatment:
They ran shortage of food, so they have to come [back
to the home village]. It was quite expensive for them
to stay [in Balimo]. (41-year-old female, village,
subsistence; translation)
Where lifestyles are largely subsistence-based, food-
related factors impinge heavily on health and healthcare
practices. Limited access to money, and thus limited
ability to purchase food instead of producing it, results
in difficult choices for patients: do they continue with
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TB treatment with inadequate nutritional intake, a
choice potentially worsened by a belief in always needing
to eat with medication; or do they miss some treatment
so that they can produce adequate food, with the aim of
continuing treatment later? Such dilemmas will be fur-
ther aggravated by the degree of understanding that a
patient has about the need for treatment adherence –
poor understanding may result in poor adherence due to
a belief that it won’t matter, while good understanding




The health system plays a significant role in treatment
adherence, through facilities, staff, and education. In
Balimo, participants described the effect of education
received from health workers concerning treatment
adherence:
I was, you know, thinking like that [of not taking the
medicines], but … these other [health] officers told
me that if you miss one, one of the drugs, then you’ll
have a problem … So I was honest and I completed
the whole of the medicines. (36-year-old male, urban)
Although some participants said they were not told
anything about TB when they started on treatment,
others stated that they had been given some information
about what to expect. Education is essential for under-
standing the importance of consistent dosing and treat-
ment. The two participants who missed a dose due to
work commitments highlight the importance of flexibil-
ity when patients can’t attend for treatment, to ensure
that doses are not missed in situations when supervision
is not possible. Arrangements to cover such situations
should be raised with patients from the outset.
Health infrastructure
Accessing treatment was more difficult for people in the
villages, who primarily receive care at aid posts staffed
by health workers with minimal training. A number of
participants described receiving a routine treatment regi-
men of amoxicillin and aspirin in response to a variety
of complaints, without onward referral to Balimo for fur-
ther investigation. There was evidence of disillusionment
with such ineffective routine treatment:
And then I was given that same treatment and then I
got tired of getting same medicine. There wasn’t any
change. (53-year-old male, village, subsistence)
Disappointment with treatment could lead to delays in
diagnosis and initiating correct treatment, with attendant
risks for ongoing transmission. However, patients expressed
confidence in the effectiveness of the TB drugs once
they started:
He is telling the difference between the previous those
who were on TB treatment [loose medications], they
knew that they would not get better. They would die.
But this current one [the DOTS packs], they all know
that once the patient is on treatment, he’s getting
better. (61 year-old male, village, subsistence;
translation)
The commitment to TB treatment in the region is en-
couraging. However, further research would help to de-
termine whether unsuccessful routine use of basic
antibiotics and analgesics affects adherence once pa-
tients begin TB treatment.
Drug supply
The drug supply chain was particularly problematic in
Balimo prior to the introduction of DOTS. A complex
regimen of individual drugs and an unstable supply
chain resulted in patients being given partial courses of
medication on a first-come, first-served basis, and thus
experiencing treatment interruptions when medications
were unavailable. These interruptions created further
problems for patients who had undergone some treat-
ment, followed by resolution of symptoms, who subse-
quently couldn’t see the need to resume treatment. This
comment is from a participant whose TB appears to
have recurred:
I said ah, I still long time … without medicine. I
cannot go back. I thought I was already better.
(39-year-old male, village, subsistence)
Drug supply interruptions could become a disincentive
to seek ongoing treatment, with repeated unsuccessful
trips to Balimo resulting in diminished desire to con-
tinue trying to receive treatment.
Because two boxes containing an entire 6-month treat-
ment course are now supplied for people diagnosed with
TB, treatment with the DOTS packs is largely free of the
supply interruptions that occurred previously. However,
there was evidence of potential problems. One partici-
pant had a child who experienced a week-long treatment
interruption due to a shortage of streptomycin. Further-
more, as the Balimo airport is currently closed, the need
to use sea- and river-based transport has the potential to
make supply less straightforward.
General infrastructure
General infrastructure challenges have an important im-
pact on healthcare in the Balimo region, particularly in
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relation to transport. Travel in the area is primarily
water-based. During dry season, when water levels are
low, village access by boat is more difficult, and may en-
tail long distances by foot over rough and swampy
ground. For some, access to treatment is challenging due
to other factors, including the expense of travel:
They buy fuel and they come, but most of the people
they don’t have engines and motors, so they travel
one or two days to paddle and come. (39-year-old
female, urban, employed)
Other studies have found long travel times to be asso-
ciated with poor treatment adherence [24, 25]. This is a
potential problem for people undergoing treatment in
the Balimo region. The challenges associated with long
and difficult travel are further complicated by reliance
on subsistence agriculture. The daily need for food pro-
duction limits the amount of spare time that people have
available for treatment-seeking. Furthermore, time away
from food production can exacerbate economic burden.
Social and cultural factors
Social factors: support and discrimination
Support systems were important as both facilitators and
barriers to treatment adherence. Good support systems
facilitated treatment:
He’s a sports man, so the people, the community, they
also showed their love, and their contribution towards
him. Advising him, taking care of him. They didn’t
want him to, they didn’t want to lose him, to die of
this disease. So they gave their moral support.
(38-year-old male, urban, employed; translation)
In a setting such as Balimo, where patients are often
required to spend at least some of their treatment away
from home, the need to rely on others was recognised as
making treatment difficult:
There was some friends, my friends, but they don’t,
they didn’t look after me properly … They have their
friends, families too. They look after their [own]. ….
Yeah, it was difficult for them to look after me
properly. (41-year-old female, village, subsistence)
Some interviewees reported family members selling
goods at markets to support their treatment. Usually this
was for purchasing supplemental food, but also natural
remedies and hygiene products. There were also reports
of physical help from family members, such as fetching
household water and doing other tasks for those under-
taking treatment. Others received assistance in the form
of cash or foodstuffs.
Stigma-related difficulties in TB treatment have been
reported in the literature [21, 26]. People may experi-
ence stigma and discrimination, and support for TB pa-
tients can be actively withheld or withdrawn. Yet, there
was surprisingly little evidence in Balimo of discrimin-
ation against those with TB. In one interview it was
noted that poor family support makes the treatment ex-
perience difficult:
The other time when he had shortage of those drugs.
And ah, he would want to send his family members,
children and wife. And when they didn’t wanted to go
he would say, oh you not want me to live, so I will
not go. You don’t care for me, so what the use of me
going and getting medicine. (39-year-old male, village,
subsistence; translation)
Additionally, another participant described discrimin-
ation from the family with which she was staying:
They are not really friendly with her. Actually, they
restrict her from cooking. They don’t let her do the
cooking. … They don’t want the food that she cooks,
that they will eat. … They have negative thoughts
toward her. (29-year-old female, urban, home duties;
translation)
These were the only instances of active discrimination
described in the interview data, and reasons for the low
level of discrimination are unclear. Despite this, for the
second participant, poor support resulted in an in-
creased desire to complete treatment, as the medicine
would ‘…bring her back to life’. One health worker spec-
ulated that discrimination may be minimised due to the
cultural wantok system in PNG that emphasises aiding
friends and family in need:
It [discrimination] happens. But I haven’t seen it as a
problem here, because the cultural wantok system is
still, it’s still there. But, but it’s changing. (38-year-old
male health worker)
However, this health worker went on to say that the
support provided by the wantok system is being
challenged by a scarcity of food and income. Aware-
ness and education were also seen as contributing to
a reduction in discrimination because people had a
better understanding of the underlying causes and
transmission of TB.
There was limited mention of the role of treatment
supporters in the interviews focused on treatment expe-
riences, but their contribution was explored more fully
in the provider interviews. Treatment supporters are an
important facet of the Western Province Tuberculosis
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Program [27]. Family members are encouraged to act as
treatment supporters and observers. Additionally, a
number of villagers have been trained as treatment sup-
porters. Their roles include giving and observing treat-
ment, collecting medications for patients, raising TB
awareness at events, and reporting to health workers in
Balimo. Their role warrants further research, as in a set-
ting where access to health centres can be difficult, the
use of community-based treatment supporters is likely
to facilitate treatment adherence.
Cultural factors: religion, sorcery, and traditional remedies
Treatment adherence in Balimo is influenced by religion
and traditional beliefs. Many Gogodala people are
Christian, but traditional animistic practices were im-
portant historically, and, for many, they continue to in-
fluence daily life [28, 29]. The influence of religious and
traditional beliefs manifested in various ways, with fac-
tors facilitating adherence centring on religion. Simply
having religious beliefs and faith in God encouraged
treatment adherence:
What he is saying, that while being a [Bible] student
he got this disease. Firstly he thought he was going to
die. But then as he was going through Bible studies,
and going through God’s word, he knew that he
wouldn’t die. He would get better. So that encouraged
him to continue and to take his medications. (33-year-
old male, village, student; translation)
Another participant described continuing adherence
so that she could subsequently focus on God’s work. Re-
ligious beliefs could also be seen as an important adjunct
to biomedical treatment:
I said treatment will help me. Prayer will help me.
God will heal me from my sickness. But I really want
to see a change within my life. So I need both
treatments. In spiritually and physically. (53-year-old
male, village, subsistence)
Despite the considerable importance attached to reli-
gious beliefs by a number of participants, there was lim-
ited evidence of links between churches and TB
treatment. As a strong community organisation, with
more extensive networks and infrastructure than the
PNG government, we feel that churches should become
more involved with TB treatment in Balimo. Such in-
volvement could especially focus on treatment adher-
ence, for example with church leaders functioning as
treatment supporters. However, churches could also act
as a means of communicating the TB message through-
out the population, and facilitate screening and contact
tracing activities in their communities.
An interesting facet of TB treatment in Balimo was
the use of multiple treatment approaches by people ex-
periencing TB symptoms. Participants described moving
between different treatment options, including herbal,
biomedical, religious, and sorcery, in search of effective
treatment. Use of herbal or natural remedies was re-
ported before, during, and after TB treatment. Although
not identified as a factor in adherence, the use of such
remedies can delay treatment-seeking. In addition, sim-
ultaneous uses of herbal and biomedical treatments
raises the possibility of adverse drug interactions.
Using multiple approaches is inadvertently encouraged
when routine treatment regimens, such as the ongoing
use of amoxicillin and aspirin described previously, are
unsuccessful:
But ah, they only gave me pain medicine. So, the pain
medicine did not help … April and May I was visiting
witchdoctors, and ah, prayer peoples. At that same
[time] I was getting this pain medicine, but it was not
helping. (32-year-old male; village, employed)
Two participants said that people’s beliefs in witchcraft
were due to a lack of understanding of TB, and it is
possible that the use of multiple treatment approaches
is linked to confusion about the causes and presenta-
tion of TB:
What he’s saying those people [who believe in
witchcraft], they don’t fully understand what TB is,
the sickness itself. So when it, ah, when person is
showing signs and symptoms, they think it’s
witchcraft. (39-year-old male, village, subsistence;
translation)
For some with limited knowledge of TB, there also
seems to be a link between belief in witchcraft and the
success or failure of biomedical treatment. Participants
reported either new consideration of, or new proof
against, witchcraft in response to their treatment experi-
ence and observations:
When he was on treatment and he wasn’t getting
better he thought of being the witchcraft. (42-year-old
male, urban, employed; translation)
There was one fellow, one boy. He told me that ah, we
were taking TB medicine together, TB drugs together.
And he told me that, witchcraft. After he was getting
better and then I told him, no, I don’t think witchcraft.
What I have seen. (36-year-old male, urban)
While not surprising in such a setting, such beliefs are
particularly concerning in the face of emerging drug
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resistance, where antimicrobial regimens will be less
dependable.
Although the use of multiple treatment approaches
was common, there were exceptions. One participant
described a non-belief in witchcraft based on his reli-
gious beliefs:
People gave me these thoughts. People were telling
me about that. Somebody magicked you. That …
caused TB. People were telling me this. So they were
sending me to magic people to get treatment, but I
said no. I was only holding Bible. I cannot believe two
gods, I said. (39-year-old male, village, subsistence)
In another case, the importance of education was
highlighted by one participant, who was also a health
worker, who used only biomedical treatment. How-
ever, this participant advocated an approach that en-
couraged treatment adherence based on education
and awareness, while also taking into account the
knowledge, beliefs and experiences of patients:
… [my] awareness to them, is that TB is a disease
itself, its cause is by a bacteria. And it’s nothing to do
with witchcraft or even with sin. It’s just like a
sickness, with our malaria causes. Mosquito causes
the malaria. And it has got its own treatment to get
better … And it’s more got to be community-based, or
person-based, not us. Yeah, they need to ask a lot of
questions. Give them time to view out what TB is,
then upon their positions, or upon how they
respond, then we can fall in to see where we can
give them health awareness … Get into the shoes
how they live, what they really need, then you
can pass the information. (39-year-old female,
urban, employed)
In this context, understanding and awareness that fits
with existing cultural norms and beliefs, and which is
sensitive to the level of education of the majority of the
population in the area, are key factors in adherence.
Health workers in the district are already working on
public health education about TB awareness, particularly
at large events such as the Gogodala festival [27]. This
essential education may be further enhanced by under-
standing the underlying sociocultural attitudes and prac-
tices present in the community.
Conclusions
Overall, people in the Balimo region being treated for
TB demonstrated a high level of confidence in the use of
DOTS-based treatment to cure TB, when and if they
were able to access such treatment. However a variety of
personal, systems, and sociocultural factors had the
potential to influence a person’s adherence to TB treat-
ment. These factors are outlined in Fig. 2, with reference
to stages of the treatment journey undertaken by TB pa-
tients, along with recommendations for how the DOTS
approach may be adapted to address such factors in this
setting. Understanding these factors is essential when
adapting the DOTS control strategy to suit local
conditions.
In the Balimo region, sheer necessity has already
led to flexibility in the delivery of the DOTS strategy.
Local adaptations to DOTS, based on the identified
challenges to its implementation, should be formalised
to ensure consistency in healthcare delivery. In addition, a
structured approach to evaluating patient needs,
based on such adaptations, would be useful in ensur-
ing that patients are accommodated before complica-
tions arise.
Greater involvement of community networks and
churches is likely to provide substantial benefit to TB
services in this region. Successfully treated former pa-
tients can provide support and services to new patients,
especially in a society where community links are
already strong and highly valued.
Education, or the lack of it, was identified as sig-
nificant in relation to many factors. Where patients
receive inadequate education about their condition
and treatment, this may reflect the heavy work
burden faced by healthcare workers. However, educa-
tional services such as those received by new pa-
tients, could easily be provided by appropriately
trained former patients.
Expanding the involvement of churches and treatment
supporters may enhance treatment adherence, commu-
nication of the TB message; and screening and contact
tracing activities. Furthermore, such an approach may
ease the workload for hospital staff who currently have
high work burdens. This should be explored through
further research and focus groups, with a view to under-
taking pilot projects with willing church groups and
former patients.
A number of factors specific to the Balimo setting may
act to facilitate TB control in this region. Confidence in
the ability of the TB drugs to cure TB, especially when
witnessed in others, is encouraging. This bodes well for
the continued desire of people to seek care for their
symptoms. In addition, for many people the successful
completion of treatment encouraged them to provide
testimony of their cure to others, which provides the
means for establishing patient support groups in the re-
gion. Finally, the strong and positive influence of religion
and churches provide a ready-made network through
which TB services can be delivered.
There is no doubt that the DOTS program in
Balimo is highly-regarded by both patients and health
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workers alike. However, the strategy is challenged in
this region by a number of factors, particularly relat-
ing to patient understanding of TB, food security,
transport and access difficulties, and the need for
flexibility in treatment observation. In other settings,
remote treatment monitoring using mobile phones
has been trialled with positive results for both TB
and HIV patients [30, 31]. Such an approach in this
region of PNG is possible, although limited and ex-
pensive technology may be a barrier. However, this
method of treatment support could be trialled with
patients who do have access to mobile phones.
Community consultation will be necessary to identify
the best way to implement other adaptations, such as
the provision of food with treatment or other strategies
to improve food security for TB patients; and ways to fa-
cilitate access to treatment when patients themselves
cannot attend at Balimo.
The challenges facing the DOTS strategy in Balimo
also highlight the need for broader public health
strategies that emphasise reducing TB transmission,
rather than relying primarily on treatment strategies.
In particular, in this setting where living conditions
are often crowded, and people frequently have limited
understanding of the biomedical basis of disease,
cough as the primary source of TB transmission is a
key concern. Future work in this area should focus
on this message, and investigate strategies that limit
transmission when people with TB are coughing.
Emerging drug resistance is an urgent problem for the
Western Province of PNG, including the Balimo region.
This highlights the need for better patient education to
ensure consistency in dosing, as well as increased moni-
toring of patients who appear unresponsive to treatment.
For the community, poor treatment outcomes in drug-
resistant patients may create disillusionment with treat-
ment in others. Community education and awareness of
drug resistance, including what it is and why it occurs, are
essential. In addition, facilitation of treatment adherence
will serve to improve treatment outcomes in the region.
Additional file
Additional file 1: Interview guide. Semi-structured interview guide
developed for the study. (DOCX 17 kb)
Fig. 2 Factors influencing DOTS-based diagnosis and treatment in Balimo, and suggested adaptions that may facilitate adherence. In the diagram,
factors that may act as barriers are shown with a (−) symbol, while those that may act as facilitators are shown with a (+) symbol
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